SCHEMBL9725100

SCHEMBL9725100

CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE P12821 6/20 0.55
REN P00797 4/20 0.55
KDM4E B2RXH2 1/20 0.52
F2 P00734 1/20 0.52
LMNA P02545 1/20 0.52
LTA4H P09960 1/20 0.52
MAPT P10636 1/20 0.52
PEPD P12955 1/20 0.52
ALOX15 P16050 1/20 0.52
PTGS1 P23219 1/20 0.52
HTR2A P28223 1/20 0.52
PTGS2 P35354 1/20 0.52
HRH1 P35367 1/20 0.52
THPO P40225 1/20 0.52
PMP22 Q01453 1/20 0.52
HSD17B10 Q99714 1/20 0.52
ACE2 Q9BYF1 1/20 0.52
DPP4 P27487 2/20 0.46
FAP Q12884 1/20 0.45
DPP8 Q6V1X1 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9725095 1.00 ACE (0.55) ACERENKDM4EF2LMNA
SCHEMBL30051953 0.95 ACE (0.50) ACERENKDM4EF2LMNA
SCHEMBL10655243 0.89 ACE (0.45) ACERENKDM4EF2LMNA
SCHEMBL10655235 0.89 ACE (0.45) ACERENKDM4EF2LMNA
SCHEMBL30819305 0.89 DPP4 (0.46) ACERENDPP4FAPDPP8
Bromide SCHEMBL7271475 0.88 DPP4 (0.45) ACERENDPP4FAPDPP8
SCHEMBL7090676 0.87 ACE (0.56) ACERENKDM4EF2LMNA
SCHEMBL30051485 0.85 ACE (0.49) ACERENKDM4EF2LMNA
SCHEMBL30051518 0.85 ACE (0.46) ACERENKDM4EF2LMNA
SCHEMBL30314724 0.84 DPP4 (0.63) ACERENKDM4EF2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4722234-A1 GENE CONSTRUCT COMPRISING NUCLEOTIDES ENCODING DECOY PEPTIDES FOR INHIBITING PROTEIN PHOSPHATASE 1-MEDIATED DEPHOSPHORYLATION OF PHOSPHOLAMBAN AND NUCLEOTIDES ENCODING CCN5 PROTEIN OR FRAGMENTS THEREOF, AND USE THEREOF BethphaGen Inc. (KR) 2026-04-08 EP claimed
WO-2024253408-A1 GENE CONSTRUCT COMPRISING NUCLEOTIDES ENCODING DECOY PEPTIDES FOR INHIBITING PROTEIN PHOSPHATASE 1-MEDIATED DEPHOSPHORYLATION OF PHOSPHOLAMBAN AND NUCLEOTIDES ENCODING CCN5 PROTEIN OR FRAGMENTS THEREOF, AND USE THEREOF (주)벳바젠 2024-12-12 WO claimed
US-20240315296-A1 PEPTIDE COMPOUNDS FOR FLAVOR MODULATING CJ CHEILJEDANG CORPORATION (KR) 2024-09-26 US claimed
EP-4364582-A1 PEPTIDE COMPOUNDS FOR FLAVOR MODULATING CJ Cheiljedang Corporation (KR) 2024-05-08 EP claimed
CN-117677302-A Peptide compounds for flavor modulation CJ第一制糖株式会社 2024-03-08 CN claimed
EP-4240708-A1 COMPOSITION FOR BIO STIMULATION OF PLANTS SACCO SRL (IT) 2023-09-13 EP claimed
CN-115047120-B Method for analyzing and detecting dansyl chloride derivative of dipeptide substances in white spirit Daqu 贵州茅台酒股份有限公司 2023-08-29 CN claimed
CN-113372414-B Fluorescent probe for detecting ochratoxin A and preparation method thereof 长春理工大学 2023-07-21 CN claimed
CN-116254245-A Application of protein OPAA114644 as organic phosphoric acid anhydrase 中国科学院微生物研究所 2023-06-13 CN claimed
WO-2023277549-A1 PEPTIDE COMPOUNDS FOR FLAVOR MODULATING 씨제이제일제당 (주) 2023-01-05 WO claimed
CN-115053935-A Application of lactobacillus salivarius in breeding of litopenaeus vannamei larvae 华南理工大学 2022-09-16 CN claimed
CN-115047120-A Dansyl chloride derivatization method for analyzing and detecting dipeptide substances in white spirit Daqu 贵州茅台酒股份有限公司 2022-09-13 CN claimed
WO-2022096723-A1 COMPOSITION FOR BIO STIMULATION OF PLANTS SACCO SRL (IT) 2022-05-12 WO claimed
US-20160374380-A1 SALTY TASTE ENHANCER T. HASEGAWA CO., LTD. (JP) 2016-12-29 US claimed
US-12622975-B2 Peptide-conjugated prodrugs BRANDEIS UNIVERSITY (US) 2026-05-12 US disclosed
EP-4722234-A1 GENE CONSTRUCT COMPRISING NUCLEOTIDES ENCODING DECOY PEPTIDES FOR INHIBITING PROTEIN PHOSPHATASE 1-MEDIATED DEPHOSPHORYLATION OF PHOSPHOLAMBAN AND NUCLEOTIDES ENCODING CCN5 PROTEIN OR FRAGMENTS THEREOF, AND USE THEREOF BethphaGen Inc. (KR) 2026-04-08 EP disclosed
EP-4684030-A2 METHOD OF DEPROTECTING AT LEAST ONE D-AMINO ACID AND/OR D-AMINO ACID DERIVATIVE PROTECTED FUNCTIONAL GROUP Martin-Luther-Universität Halle-Wittenberg (DE) 2026-01-28 EP disclosed
US-20220135640-A1 CORTISTATIN OR AN ANALOGUE THEREOF AS A PHARMACEUTICALLY ACTIVE AGENT IN LATENT FORM CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) 2022-05-05 US disclosed
US-20160374380-A1 SALTY TASTE ENHANCER T. HASEGAWA CO., LTD. (JP) 2016-12-29 US disclosed
US-5167957-A Di-, tri-, or tetrapeptides absorbed in the stomach; veterinary medicine VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) 1992-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12622975-B2 Peptide-conjugated prodrugs PEPD, PAM, VIP ACE 1190/4885REN 2773/4885KDM4E 1136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.